tradingkey.logo

tradingkey.logo
怜玢


Anixa Biosciences Inc

ANIX
りォッチリストに远加
2.620USD
-0.060-2.24%
終倀 11-13 16:00ET
91.07M時䟡総額
損倱額盎近12ヶ月PER

Anixa Biosciences Incに぀いお 䌁業名

Anixa Biosciences, Inc. is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. The Company's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor-T cell (CER-T) technology. The Company's vaccine portfolio includes vaccines being developed in collaboration with Cleveland Clinic to treat and prevent breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. The Company is engaged in the development of vaccines for the treatment or prevention of triple negative breast cancer and other breast cancers which express the a-lactalbumin protein. Its vaccine technologies are focused on immunizing against retired proteins that have been found to be expressed in certain forms of cancer.

Anixa Biosciences Inc プロフィヌル


䌁業コヌドANIX
䌚瀟名Anixa Biosciences Inc
䞊堎日Oct 07, 1983
最高経営責任者「CEO」Kumar (Amit)
埓業員数5
蚌刞皮類Ordinary Share
決算期末Oct 07
本瀟所圚地3150 Almaden Expy Ste 250
郜垂SAN JOSE
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号95118
電話番号14087089808
りェブサむトhttps://www.anixa.com/
䌁業コヌドANIX
䞊堎日Oct 07, 1983
最高経営責任者「CEO」Kumar (Amit)

Anixa Biosciences Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Amit Kumar
Dr. Amit Kumar
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
685.00K
+1.90%
Mr. Michael J. (Mike) Catelani
Mr. Michael J. (Mike) Catelani
President, Chief Financial Officer, Chief Operating Officer, Secretary
President, Chief Financial Officer, Chief Operating Officer, Secretary
50.00K
+11.00%
Ms. Emily Gottschalk
Ms. Emily Gottschalk
Independent Director
Independent Director
45.66K
--
Mr. Lewis H. (Lew) Titterton, Jr.
Mr. Lewis H. (Lew) Titterton, Jr.
Lead Independent Director
Lead Independent Director
--
--
Dr. Arnold Baskies
Dr. Arnold Baskies
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Amit Kumar
Dr. Amit Kumar
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
685.00K
+1.90%
Mr. Michael J. (Mike) Catelani
Mr. Michael J. (Mike) Catelani
President, Chief Financial Officer, Chief Operating Officer, Secretary
President, Chief Financial Officer, Chief Operating Officer, Secretary
50.00K
+11.00%
Ms. Emily Gottschalk
Ms. Emily Gottschalk
Independent Director
Independent Director
45.66K
--
Mr. Lewis H. (Lew) Titterton, Jr.
Mr. Lewis H. (Lew) Titterton, Jr.
Lead Independent Director
Lead Independent Director
--
--
Dr. Arnold Baskies
Dr. Arnold Baskies
Independent Director
Independent Director
--
--

よくある質問

Anixa Biosciences Incの䞊䜍5名の株䞻は誰ですか


Anixa Biosciences Incの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Amit Kumar

Anixa Biosciences IncANIXの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Anixa Biosciences Incの株匏を保有しおいる機関は119瀟あり、保有株匏の総垂堎䟡倀は玄5.84Mで、党䜓の17.43%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-36580.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。